These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 8923032)

  • 21. Genetic and cellular changes in colorectal cancer: proposed targets of chemopreventive agents.
    Greenwald P; Kelloff GJ; Boone CW; McDonald SS
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):691-702. PubMed ID: 8672984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprevention by isothiocyanates and their underlying molecular signaling mechanisms.
    Keum YS; Jeong WS; Kong AN
    Mutat Res; 2004 Nov; 555(1-2):191-202. PubMed ID: 15476860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action.
    Husain SS; Szabo IL; Tamawski AS
    Am J Gastroenterol; 2002 Mar; 97(3):542-53. PubMed ID: 11922545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tea antioxidants in cancer chemoprevention.
    Katiyar SK; Mukhtar H
    J Cell Biochem Suppl; 1997; 27():59-67. PubMed ID: 9591194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer.
    Kelloff GJ; Sigman CC; Johnson KM; Boone CW; Greenwald P; Crowell JA; Hawk ET; Doody LA
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):127-37. PubMed ID: 10698472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1,4-phenylenebis(methylene)selenocyanate exerts exceptional chemopreventive activity in rat tongue carcinogenesis.
    Tanaka T; Makita H; Kawabata K; Mori H; El-Bayoumy K
    Cancer Res; 1997 Sep; 57(17):3644-8. PubMed ID: 9288763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation (Review).
    Pathak SK; Sharma RA; Mellon JK
    Int J Oncol; 2003 Jan; 22(1):5-13. PubMed ID: 12469179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat.
    Wargovich MJ; Chen CD; Jimenez A; Steele VE; Velasco M; Stephens LC; Price R; Gray K; Kelloff GJ
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):355-60. PubMed ID: 9162301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting specific cell signaling transduction pathways by dietary and medicinal phytochemicals in cancer chemoprevention.
    Neergheen VS; Bahorun T; Taylor EW; Jen LS; Aruoma OI
    Toxicology; 2010 Dec; 278(2):229-41. PubMed ID: 19850100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methods and strategies in lung cancer control.
    Castonguay A
    Cancer Res; 1992 May; 52(9 Suppl):2641s-2651s. PubMed ID: 1562994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells.
    Nair S; Li W; Kong AN
    Acta Pharmacol Sin; 2007 Apr; 28(4):459-72. PubMed ID: 17376285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent.
    López-Lázaro M
    Mol Nutr Food Res; 2008 Jun; 52 Suppl 1():S103-27. PubMed ID: 18496811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of dietary phytochemical chemopreventive agents: biomarkers and choice of dose for early clinical trials.
    Scott EN; Gescher AJ; Steward WP; Brown K
    Cancer Prev Res (Phila); 2009 Jun; 2(6):525-30. PubMed ID: 19470784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemoprevention of large bowel carcinogenesis; the role of control of cell proliferation and significance of beta-catenin-accumulated crypts as a new biomarker.
    Mori H; Yamada Y; Hirose Y; Kuno T; Katayama M; Sakata K; Yoshida K; Sugie S; Hara A; Yoshimi N
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S71-5. PubMed ID: 12570338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carcinogen biomarkers for lung or oral cancer chemoprevention trials.
    Hecht SS
    IARC Sci Publ; 2001; 154():245-55. PubMed ID: 11220664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Summary of recommendations for colonic biomarker studies of candidate chemopreventive compounds in phase II clinical trials.
    Lipkin M
    J Cell Biochem Suppl; 1994; 19():94-8. PubMed ID: 7823612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways.
    Ramos S
    Mol Nutr Food Res; 2008 May; 52(5):507-26. PubMed ID: 18435439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Terpenoids and breast cancer chemoprevention.
    Rabi T; Bishayee A
    Breast Cancer Res Treat; 2009 May; 115(2):223-39. PubMed ID: 18636327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological relevance of adduct detection to the chemoprevention of cancer.
    Sharma RA; Farmer PB
    Clin Cancer Res; 2004 Aug; 10(15):4901-12. PubMed ID: 15297390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Importance of chemoprevention in oncology].
    Aragona M; Panetta S; Rizzotti P; La Torre I; Giudice A; La Torre F
    Minerva Med; 2000; 91(7-8):169-77. PubMed ID: 11155466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.